Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...
Eli Lilly’s weight loss drug Zepbound is no longer in short supply ... themselves the incorrect dose of off-brand drugs. "These dosing errors resulted from patients measuring and self ...